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Previous reports have noted depression after West
Nile virus (WNV) infection. We further measured this out-
come and found that 31% of patients reported new-onset
depression and 75% of these had Center for Epidemiologic
Studies Depression scores indicative of mild-to-severe
depression. Physicians should be aware of neuropsychi-
atric consequences of WNV in patients.
W
est Nile virus (WNV) was identified for the first
time in the Western Hemisphere in New York City in
1999; since then, a dramatic westward and southward
spread of WNV activity has occurred in the United States
(1,2). In 2002, WNV was identified in the Houston, Texas,
metropolitan area, resulting in 105 human cases (3).
Long-term clinical sequelae after infection are still
being defined. A year after the outbreak of WNV in New
York City, 38% of patients subjectively reported depres-
sion (4). Another 1-year follow-up in Colorado noted that
23% of patients reported anxiety and depression (5). In
Houston, we have been conducting a prospective study
that involves both subjective and objective measurements
of physical, neurologic, and cognitive functioning of
patients identified with symptomatic WNV infections. We
describe the subjective and objective evaluations of
depression in these patients.
The Study
Clinical WNV patients, confirmed by immunoglobu-
lin M ELISA and identified through local surveillance in
the Houston metropolitan area from 2002 through 2004,
were invited to participate in a study to determine long-
term clinical sequelae. Those consenting to participate
were interviewed. No patient was denied participation on
the basis of age, sex, race, or ethnicity. Excluded patients
included those who were residing outside of the Houston
area, deceased, or lost to follow-up. This study was
reviewed and approved by the University of Texas Health
Science Center Institutional Review Board (HSC-SPH-
03–039).
Initial interviews were conducted after hospitaliza-
tion, and follow-up interviews were conducted every 6
months until the patient reported being back to pre-WNV
infection functioning. For the 1-year follow-up, inter-
views were conducted during each December at the end of
transmission season. Interviews were mainly conducted
over the telephone, but a small proportion were conduct-
ed in person. In all of these interviews, a higher than
expected proportion of patients reported depression
immediately after their illness. To better assess this quan-
titatively, we incorporated the Center for Epidemiologic
Studies Depression (CES-D) scale (6) into both initial and
follow-up interviews. This scale is a commonly used
method for objective measurement of clinical depression.
The tool is composed of 20 questions focused on self-
report of depressive moods and behavioral changes expe-
rienced by the patient during 1 week. The resulting scores
were interpreted as follows: 1) <15, the patient is not
experiencing depression; 2) 15–21, the patient may be
experiencing mild-to-moderate depression; 3) >22–60,
the patient may be experiencing major depression. In
addition to the objective measurement using the CES-D
scale, we also asked patients if they were experiencing
depression since their illness and if they had a previous
history of depression, with yes/no responses elicited.
Barthel Index scores were used to quantitatively evaluate
level of physical functioning and disability in patients; a
score of 100 points indicated no physical disability.
Because patients also commonly reported a change in per-
sonality immediately after WNV infection, we assessed
this finding subjectively and asked those reporting a
change to describe what they were experiencing.
Data were analyzed by using NCSS statistical soft-
ware (Kaysville, UT, USA). With the Kruskal-Wallis 1-
way analysis of variance on ranks, we analyzed CES-D
scores and WNV outcome; CES-D scores and sex, age,
and depression (CES-D score of >15); and physical func-
tioning (Barthel Index) and depression. 
A total of 65 patients were interviewed; 38 (58%)
cases had encephalitis when initially evaluated, 19 (29%)
had meningitis, and 8 (12%) had fever. The mean age of
patients was 55 years (range 12–86 years). Most patients
were white, non-Hispanic (80%), followed by black (11%)
and white, Hispanic (9%).
One year after infection with WNV, 26 patients report-
ed experiencing depression. Of these, 6 reported a history
of depression before infection. Of the 20 patients consid-
ered to have new-onset depression, 13 (65%) had a clinical
diagnosis of WNV encephalitis (Table), and 10 (50%)
were male. The mean CES-D scores for those who report-
ed no depression was 5.5 (range 0–19) compared with a
mean score of 22 (range 0–44) for those who reported
depression. There was no statistical difference in CES-D
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had meningitis or fever (p = 0.19) or between those with
West Nile neuroinvasive disease (encephalitis or meningi-
tis) compared with those with fever (p = 0.55). On the
basis of CES-D scores for those self-reporting depression
since their illness with WNV, 5 (25%) patients were clas-
sified by CES-D as not depressed, 6 (30%) were classified
as having mild-to-moderate depression, and 9 (45%) were
classified as having major depression. Of the 39 patients
who self-reported that they had not had depression since
their WNV illness, 4 had a CES-D score of >15. No statis-
tically significant associations were found between loss of
physical functioning (Barthel index scores <100; p = 0.39),
sex (p = 0.89), or age (p = 0.47) and depression (CES-D
scores of >15).
Seven (35%) patients reported taking antidepressants
for their symptoms; 4 of these patients reported at least
some improvement. CES-D scores of 6 of these 7 patients
were >15; 4 showed evidence of major depression. Two
patients reported seeing a counselor for depression, includ-
ing 1 who was also taking antidepressants. Both patients
reported that the counseling was helpful; however, based
on their CES-D scores, both were classified as having
major depression at the time of the interview.
Personality changes were reported subjectively among
29 (45%) of the 65 patients (Table); 18 (62%) of these
were in patients who had encephalitis, and 16 (55%) of
these patients were male. When asked to describe their per-
sonality change, 19 patients (66%) reported an increase in
anger (being short-tempered and irritable); 8 patients
(28%) reported being less social; 3 patients (10%) report-
ed increased sensitivity; and 1 patient (3%) reported feel-
ings of hopelessness.
Conclusions
Depression and personality changes after WNV infec-
tion have been briefly observed in previous studies (4,5);
however, this study is the first known to objectively eval-
uate this outcome. As evidenced by subjective and objec-
tive measurements, depression is an important outcome in
patients with a clinical diagnosis of WNV infection:
indeed, 75% of those reporting no previous history of
depression had high CES-D scores. Understanding the
pathology of this outcome and determining whether the
depression is situational (a result of prolonged recovery) or
caused by chemical changes in the brain related to inflam-
mation are critical. Depression was not associated with
loss of physical functioning, sex, or age.
Depression after encephalitis, regardless of etiology,
is not uncommon. Depression and personality changes in
humans have been previously reported as a neuropsychi-
atric consequence of Lyme disease, Nipah virus, tickborne
encephalitis virus, and Saint Louis encephalitis virus infec-
tions (7–10). After the encephalitis lethargica pandemic
from 1917 to 1926, depression, mania, and obsessive-com-
pulsive disorder were observed in postencephalitis patients
(11). These observations led to the understanding of the
role of the basal ganglia in mood, personality, and obses-
sional syndromes. In a mouse model experiment, infection
of the brain with Venezuelan equine encephalitis virus
resulted in a serotonin presynaptic deficit and postsynaptic
hyperreactivity of the serotonin system (12).
Inflammation of the brain can result in an alteration in
the neurotransmitter serotonin, which may lead to the
development of mood disorders (13). Capuron et al. iden-
tified a significant proportion of patients in whom depres-
sion developed after cytokine therapy for cancer. The
neurotoxic inflammation induced by cytokines resulted in
DISPATCHES
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for serotonin. This decrease was positively correlated with
the development and severity of depressive symptoms in
patients.
The long-term clinical sequelae of WNV neuroinva-
sive disease need to be further defined. By understanding
potential outcomes and determining whether certain inter-
ventions such as physical therapy, counseling, and antide-
pressant drug therapy can improve recovery, we can better
understand prognosis and potential treatment interven-
tions. Physicians should note that depression and personal-
ity changes could be important neuropsychiatric
consequences in patients with clinical WNV infection.
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